Medicine News Car T Cell Therapy Reaches Beyond Cancer Penn Medicine

Study reveals why some myeloma patients stay cancer-free for years after CAR T therapy

A new study from the Icahn School of Medicine at Mount Sinai helps explain why some people with multiple myeloma, a type of blood cancer, stay in remission for many years after receiving CAR T cell ... Read More

Penn researchers utilize 'tumor-on-a-chip' devices to explore cancer treatments

This month, the group published new information regarding the mechanisms of immunotherapies, focusing on antigen receptor CAR T-cell therapy. Read More

Next-generation CAR T cells could expand solid cancer treatment options

Chimeric antigen receptor (CAR) T cell therapy, which uses a patient's own immune cells to fight cancer, has emerged as a powerful way to treat lymphoma and other blood cancers. But researchers have ... Read More

From blood to solid tumors: A new way to power up CAR T cell therapy

T cell therapies have revolutionized cancer treatment—but so far, their success has been largely limited to blood cancers. Solid tumors, which account for around 90% of all adult cancers, remain a ... Read More

Penn professor Carl June discusses medical innovation award, CAR-T cell research in DP interview

Penn Medicine professor Carl June was recently awarded the Broermann Medical Innovation Award 2025 for his work on utilizing CAR-T cells in cancer therapy. Modifying T-cells with chimeric antigen ... Read More

How In Vivo CAR T-Cell Therapies Could Rewrite the Cancer Care Playbook

In vivo CAR T-cell therapies could improve access by eliminating complex logistics and reducing costs, making them more accessible to underserved populations. Traditional CAR T-cell therapies face ... Read More

Penn’s CAR-T pioneer Carl June talks about the future of his award-winning work to train the body to fight cancer

Philadelphia’s pioneering cancer scientist, Carl June, has been honored with two awards in the last month for his seminal work engineering the body’s immune system to fight cancer. June has spent ... Read More

A new arrival at University of Colorado Cancer Center tests a homegrown treatment for aggressive leukemia

A physician-scientist who last year joined the University of Colorado Cancer Center team will soon steer the first human trial of a homegrown novel chimeric antigen receptor (CAR) T-cell therapy for ... Read More

MagicRNA's First-in-Human Clinical Data Demonstrating Feasibility of In Vivo CAR T Therapy in Systemic Lupus Erythematosus Published in The New England Journal of Medicine.

SHENZHEN, China, Sept. 17, 2025 /PRNewswire/ -- MagicRNA, a clinical-stage biotechnology company pioneering in vivo CAR T-cell therapies, today announced the publication of the world's first clinical ... Read More

Mount Sinai study reveals why some myeloma patients stay cancer-free for years after CAR T therapy

A new study from the Icahn School of Medicine at Mount Sinai helps explain why some people with multiple myeloma, a type of blood cancer, stay in remission for many years after receiving CAR T cell ... Read More